Literature DB >> 3591467

Hypoalphalipoproteinemia resembling fish eye disease.

J Frohlich, G Hoag, R McLeod, M Hayden, D V Godin, L D Wadsworth, J D Critchley, P H Pritchard.   

Abstract

A 16-year-old boy presented with bilateral arcus cornealis and markedly decreased plasma high density lipoprotein cholesterol. The plasma lipoprotein abnormalities, as well as decreased mass and activity of lecithin:cholesterol acyltransferase (LCAT), were similar to those described in patients with fish eye disease. Increased number of target cells and decreased osmotic fragility of the proband's erythrocytes were noted. The proband's father and one of his brothers showed intermediate plasma lipoprotein and LCAT alterations. The father's erythrocytes also showed abnormal osmotic fragility. The mother of the propositus had normal plasma lipoproteins and erythrocyte osmotic fragility, but her LCAT activity was also low. Many of these features suggest a disorder similar to fish eye disease which is clinically and biochemically distinct from other hypoalphalipoproteinemias.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3591467     DOI: 10.1111/j.0954-6820.1987.tb00896.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  8 in total

1.  A first British case of fish-eye disease presenting at age 75 years: a double heterozygote for defined and new mutations affecting LCAT structure and expression.

Authors:  A F Winder; J S Owen; P H Pritchard; D Lloyd-Jones; D T Vallance; P White; R Wray
Journal:  J Clin Pathol       Date:  1999-03       Impact factor: 3.411

2.  A molecular defect causing fish eye disease: an amino acid exchange in lecithin-cholesterol acyltransferase (LCAT) leads to the selective loss of alpha-LCAT activity.

Authors:  H Funke; A von Eckardstein; P H Pritchard; J J Albers; J J Kastelein; C Droste; G Assmann
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

3.  A retractable lid in lecithin:cholesterol acyltransferase provides a structural mechanism for activation by apolipoprotein A-I.

Authors:  Kelly A Manthei; Joomi Ahn; Alisa Glukhova; Wenmin Yuan; Christopher Larkin; Taylor D Manett; Louise Chang; James A Shayman; Milton J Axley; Anna Schwendeman; John J G Tesmer
Journal:  J Biol Chem       Date:  2017-10-13       Impact factor: 5.157

4.  A frameshift mutation in the human apolipoprotein A-I gene causes high density lipoprotein deficiency, partial lecithin: cholesterol-acyltransferase deficiency, and corneal opacities.

Authors:  H Funke; A von Eckardstein; P H Pritchard; M Karas; J J Albers; G Assmann
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

5.  Two different allelic mutations in the lecithin-cholesterol acyltransferase gene associated with the fish eye syndrome. Lecithin-cholesterol acyltransferase (Thr123----Ile) and lecithin-cholesterol acyltransferase (Thr347----Met).

Authors:  H G Klein; P Lohse; P H Pritchard; D Bojanovski; H Schmidt; H B Brewer
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

6.  Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease.

Authors:  D J Rader; K Ikewaki; N Duverger; H Schmidt; H Pritchard; J Frohlich; M Clerc; M F Dumon; T Fairwell; L Zech
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

Review 7.  Analysis of familial hypoalphalipoproteinemia syndromes.

Authors:  J Frohlich; P H Pritchard
Journal:  Mol Cell Biochem       Date:  1992-08-18       Impact factor: 3.396

Review 8.  A systematic review of the natural history and biomarkers of primary lecithin:cholesterol acyltransferase deficiency.

Authors:  Cecilia Vitali; Archna Bajaj; Christina Nguyen; Jill Schnall; Jinbo Chen; Kostas Stylianou; Daniel J Rader; Marina Cuchel
Journal:  J Lipid Res       Date:  2022-01-20       Impact factor: 5.922

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.